Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
Clinical trial NCT03756129 · COMPLETED
Trial details
- NCT number
- NCT03756129
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-08
- Primary completion
- 2020-03-23
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.